SGLT2 Inhibitor and Urinary Tract Infection in Men at Risk for Voiding Dysfunction: A VigiBase Analysis
This study suggests an elevated risk for both UTIs and complex UTIs in men taking SGLT2 inhibitors, with a more pronounced risk for complex UTI in older men who may have benign prostatic hyperplasia-related voiding dysfunction. These findings highlight the need for a balanced approach in prescribing SGLT2 inhibitors, particularly in populations potentially more susceptible to UTIs.
Authors
- Alexander P. Cole
- Zhiyu Qian
- Daniel Stelzl
- Hanna Zurl
- Muhieddine Labban (ORCID: https://orcid.org/0000-0002-4580-1915)
- Lori B. Lerner (ORCID: https://orcid.org/0000-0001-9403-4575)
- Boyuan Xiao (ORCID: https://orcid.org/0000-0001-7194-2693)
- Brian Tao
- Filippo Dagnino
- J.W. Song
- Alyssa Jones
- Quoc-Dien Trinh (ORCID: https://orcid.org/0009-0002-6752-0388)
Institutions
- Boston University (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- VA Boston Healthcare System (US)
Publication Details
- Journal
- Urology Practice
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1097/upj.0000000000000698
- Citations
- 1
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.54